Full EIS Report
eXroid was founded in 2013 to bring Ultroid US electrotherapy treatments for haemorrhoids from the US to Europe. The company has subsequently severed ties with the US group and is developing its own electrotherapy machines in order to treat patients in clinics throughout the UK.
15 Mar 18
Gold Due Diligence for GrowthInvest
Ascendant Films Limited (AFL) is a UK-based maker and distributor of films, TV programmes and documentaries. It is raising money to produce three new films and plans to distribute its own content on a new digital platform, potentially boosting film profits. Through an associate (Ascendant Releasing), it will distribute third-party films.
09 Feb 18
The need for consistency
According to the US Securities and Exchange Commission, “Cashflow statements report a company’s inflows and outflows of cash”. This is such a simple and obvious statement. Unfortunately, the failure of accounting bodies around the world to adopt a consistent reporting method means that the derivation of operational cashflows, is anything but simple and consistent. To highlight the issue, a survey of the companies that comprise the FTSE 100 shows that the ‘indirect’ approach is used by the majority (70%) of companies. There is recognition for the need to improve with a discussion paper issued by the UK Financial Reporting Council entitled ‘Improving the Statement of Cash Flows’.
18 Sep 17
Real-time access to the latest equity research, for the first time.
Historically, Private Investors have had access to significantly less professional investment research and information than institutions, funds, and banks. At Research Tree, we're trying level that playing field by aggregating the latest equity research & video content from over 400 analysts at 35+ City brokerages and research houses in one platform.
Our goal is simple: provide retail and institutional investors with full access to the latest valuations, target prices, analysis, and financial models on the companies they care about, in real-time.
Research Tree aggregates the latest equity research from over 400 analysts at 35+ City brokerages and research houses in one platform, giving users full access to the latest valuations, target prices, analysis, and financial models on the companies they care about, in real-time.